Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis

Frontiers in Medicine

Sarah Twigg¹ 

关键词: comorbidities;    inflammatory arthritis;    rheumatoid arthritis;    cyclic citrullinated peptide antibodies;    at-risk of arthritis;    depression and anxiety disorders;   

DOI  :  10.3389/fmed.2018.00035

学科分类：医学（综合）

来源: Frontiers

【 摘 要 】

ObjectivesTo compare comorbidities in a cohort of cyclic citrullinated peptide (CCP) antibody positive patients without or prior to onset of inflammatory arthritis (IA) to those in patients with early IA.

【 授权许可】

CC BY